Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
10.49
-0.71 (-6.34%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $707.34 million as of July 2, 2024. Its market cap has increased by 254.56% in one year.

Market Cap
707.34M
Enterprise Value
529.39M
1-Year Change
254.56%
Ranking
Category
Stock Price
$10.49

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $707.34M, an increase of 1,320.36%. That is a compound annual growth rate of 15.29%.

History

DateMarket Cap% Change
Jul 1, 2024697.30M518.17%
Dec 29, 2023112.80M221.37%
Dec 30, 202235.10M-36.18%
Dec 31, 202155.00M39.95%
Dec 31, 202039.30M-6.65%
Dec 31, 201942.10M108.42%
Dec 31, 201820.20M-8.18%
Dec 29, 201722.00M-31.03%
Dec 30, 201631.90M-38.18%
Dec 31, 201551.60M-35.58%
Dec 31, 201480.10M317.19%
Dec 31, 201319.20M-28.89%
Dec 31, 201227.00M41.36%
Dec 30, 201119.10M-28.20%
Dec 31, 201026.60M30.39%
Dec 31, 200920.40M343.48%
Dec 31, 20084.60M-90.09%
Dec 31, 200746.40M-40.28%
Dec 29, 200677.70M9.75%
Dec 30, 200570.80M42.17%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Mesoblast 737.24M
Nuvation Bio 736.57M
Harrow Health 734.35M
CARGO Therapeutics 732.64M
The Pennant Group 730.05M
HilleVax 722.69M
Ginkgo Bioworks Holdings 710.48M
Immunome 703.44M
Market Cap Rankings